Rocky Fentonics, one of the suppliers of biological sensors for Apple’s smartwatch, yesterday unveiled a digital health sensor system called “Clinic-on-Wrist-Wrist” that enables wearable devices with several biological indicators such as body temperature, blood pressure, Control hydration and blood alcohol levels, lactic acid and glucose uptake.
Using a small chip-based solution with optical sensors that provide continuous, non-invasive monitoring of various biological markers, the technology seeks to address many of the challenges associated with wearable device health monitoring and avoid the need for aggressive sensors. Slowly Invasive sensors are cases that require piercing of the skin for biological measurement. For example, current glucose sensors must pierce and draw blood using a small needle.
Currently, many wearables use green LEDs to monitor heart rate; But the Rocky sensor uses infrared spectrophotometers that can detect and control a wider range of biological markers to dramatically increase the performance of wearable devices. The sensor generates laser beams for non-invasive exploration under the skin to analyze blood, mucous fluids and dermal layers for specific compounds and physical phenomena.
Rockley is said to be launching a multi-purpose solution in the form of a wristband that includes a sensor module and a communication program, and the system will reportedly be used in a number of human studies in the coming months. Rockley has announced that the sensor module and related reference designs, including hardware and application firmware, will be available for other consumer products.
Earlier this year, it was revealed that Apple is Rocky Photonix’s largest customer. According to the company’s files, the company has earned the most revenue from Apple in the last two years, and apparently has a continuous production and development agreement with Apple, according to which its revenue is expected to be guaranteed for many years.
Given the growth of Rocky Photonics and Apple’s partnership with the company, it is very likely that the company’s biological sensor technology will sooner or later be used in the Apple Watch and bring new capabilities to the tech giant smartwatches. Rockley has previously said that the sensor could be installed in consumer watches and other electronics soon next year, which is almost in line with the Apple Watch 8 Series models.
For years, rumors have been circulating about the Apple Watch’s important feature for monitoring blood glucose, which allows users to check their blood sugar levels through this wearable device. According to previous reports, this feature could appear in the eighth generation of Apple’s smartwatch, and potentially, the Apple Watch 8 Series will achieve the feature of non-invasive blood sugar control. According to available reports, this feature is being tested and tested before commercialization for reliability and stability.
Based on Rockley’s achievement, it is predicted that the Apple Watch will be equipped with glucose control to determine blood sugar levels in the near future without the need to take the patient’s blood. According to a report in 1995, Tim Cook (Apple CEO) participated in glucose control tests. He admitted to using a continuous blood sugar monitor for several weeks. This feature is life-changing for type 1 diabetics who need to monitor their blood sugar levels through a continuous blood pressure monitor (CGM) or fingers throughout the day; But it can take years for diabetics to reach the level of precision needed before taking a dose of insulin.